期刊文献+

白藜芦醇衍生物在大鼠尿液中代谢产物结构及代谢途径研究

Studies on metabolic structures and pathways of resveratrol derivative in rat urine
原文传递
导出
摘要 目的:研究大鼠尿液中白藜芦醇衍生物(E)-3,5,4′-三甲氧基-1,2-二苯乙烯(BTM-0512)的主要代谢产物结构及代谢途径。方法:尿样采用C18固相萃取小柱(SPE)处理,用LC/MS/MS技术分析推测BTM-0512在大鼠体内代谢产物的结构,结合UV、IR、NMR等技术对代谢产物M1进行结构确证。结果:BTM-0512在大鼠体内有多种代谢物,所建立的LC/MS/MS方法可用于寻找并鉴定主要代谢产物。结论:首次从大鼠尿液中鉴定出3个Ⅰ相和1个Ⅱ相代谢产物(M1-M4),推断出BTM-0512在大鼠体内的代谢途径,并确证了代谢产物M1的结构。 Objective:To identify the major metabolites and metabolic pathways of resveratrol derivative (E)-3,5,4'-trimethoxystilbene,BTM-0512) in rat urine.Methods:Samples were pretreated by using solid-phase extraction technique (SPE) with C18 cartridges,and a LC/MS/MS method with electrospray ionization (ESI),positive ion mode and collision induced dissociation (CID),was used to elucidate the structures of the major metabolites of BTM-0512.UV,IR and NMR were used to identify the structures of M1. Results:The results proved that the LC/MS/MS method established was simple,reliable and sensitive,and can be easily screened and identified the structures of the major metabolites of BTM-0512 in rat urine;it was better to understand its in vivo metabolism.Conclusion:The main metabolites of BTM-0512 are three phase Ⅰand one phase Ⅱmetabolites in rat urine,the possible metabolic pathways is proposed for the first time.The structure of M1 is authenticated by combining with spectra technologies.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第12期1994-2001,共8页 Chinese Journal of Pharmaceutical Analysis
基金 "重大新药创制"科技重大专项(2009ZX09103-012
关键词 (E)-3 5 4′-三甲氧基-1 2-二苯乙烯 代谢物 液相色谱-串联质谱 (E)-3 5 4′-trimethoxystilbene metabolite LC/MS/MS
  • 相关文献

参考文献9

  • 1Venera Cardile,Laura Lombardo,Carmela Spatafora,et al.Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues.Bioorg Chem,2005,33:22.
  • 2Belleri M,Ribatti D,Nicoli S,et al.Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4- trimethoxystilbene.Mol Pharmacol,2005,67(5):1451.
  • 3Chabert P,Fougerousse A,Brouillard R.Anti-mitotic properties of resveratrol analog (Z)-3,5,4-trimethoxystilbene.Biofactors,2006,27(1-4):37.
  • 4Schneider Y,Chabert P,Stutzmann J,et al.Resveratrol analog (Z)-3,5,4-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerzation.Int J Cancer,2003,107(2):189.
  • 5Daniele Simoni,Marinella Roberti,Francesco Paolo Invidiata,et al.Stilbene-based anticancer agents:Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.Bioorg Med Chem Lett,2006,16:3245.
  • 6Hisashi Matsuda,Supinya Tewtrakul,Toshio Morikawa,et al.Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.):structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-a and IL-4 in RBL-2H3 cells.Bioorg Med Chem,2004,12:4871.
  • 7Vincent Farines,Marie-Carmen Monje,Joao Paulo Telo,et al.Polyphenols as superoxide dismutase modulators and ligands for estrogen receptors.Anal Chim Acta,2004,513:103.
  • 8Ugo Azzena,Giovanna Dettori,Maria Vittoria Idini,et al.Regioselective reductive demethoxylation of 3,4,5-trimethoxystilbenes.Tetrahedron,2003,59:7961.
  • 9Wang DG,Hang TJ,Wu CY,et al.Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS.J Chromatogr B,2005,829:97.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部